Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Continuous Glucose Monitoring and Connected Insulin Pens on Glycemic Control in Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections.

NCT06311019 is registered in ClinicalTrials.gov with Klavs Würgler Hansen as lead sponsor.

NCT NCT06311019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06311019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Continuous Glucose Monitoring and Connected Insulin Pens on Glycemic Control in Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections.
Lead sponsor
Klavs Würgler Hansen
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 27, 2024
Completion date
September 1, 2025
Enrollment
104 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes treated with insulin